| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,435 | 14,725 | 22,232 | 28,799 | | Cost of Revenue | 2,609 | 2,877 | 2,603 | 3,693 | | | Gross Profit | 1,826 | 11,848 | 19,629 | 25,106 | | | Operating Expenses | | Research Development | 17,174 | 20,258 | 20,069 | 22,700 | | Selling General and Administrative | 5,008 | 4,555 | 5,411 | 5,805 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (20,356) | (12,965) | (5,851) | (3,399) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 563 | 705 | (236) | (2,831) | | Earnings Before Interest And Taxes | (19,793) | (12,260) | (6,087) | (6,230) | | Interest Expense | 1,270 | 944 | 716 | 475 | | Income Before Tax | (21,063) | (13,204) | (6,803) | (6,705) | | Income Tax Expense | 3 |
-
| 6 | (12) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,066) | (13,204) | (6,809) | (6,693) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,066) | (13,204) | (6,809) | (6,693) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,066) | ($13,204) | ($6,809) | ($6,693) |
|
0.11% Nasdaq 
0.01%
Income Statement
